mTOR-understanding the clinical effects.

Area of Science:

• Cell Biology
• Immunology
• Vascular Biology

Background:

• The target of rapamycin (TOR) is a conserved serine/threonine kinase regulating cell growth and metabolism.
• Mammalian target of rapamycin (mTOR) is the human homologue of yeast TOR, playing critical roles in cellular processes.
• mTOR signaling is influenced by nutrients, growth factors, energy status, and cellular stress.

Purpose of the Study:

• To review the role of mTOR-inducible signals in the protection and survival of effector and regulatory T cells.
• To examine the function of mTOR in endothelial cell biology, including growth, survival, and proliferation.
• To discuss the clinical relevance of mTOR in endothelial cells, particularly in the context of transplant rejection.

Main Methods:

• Literature review focusing on mTOR signaling pathways.
• Analysis of studies investigating mTOR's role in T cell and endothelial cell function.
• Evaluation of clinical implications and therapeutic applications of mTOR inhibitors.

Main Results:

• mTOR signaling is vital for the survival and function of both effector and regulatory T cells.
• mTOR plays a significant role in vascular endothelial cell proliferation, survival, and overall health.
• Dysregulation of mTOR in endothelial cells may contribute to the rejection process in solid organ transplantation.

Conclusions:

• mTOR signaling is a key regulator of immune cell and vascular cell biology.
• Targeting mTOR pathways offers therapeutic potential for managing transplant rejection.
• Optimal use of mTOR inhibitors can improve outcomes following solid organ transplantation.